See more : NGL Fine-Chem Limited (NGLFINE.NS) Income Statement Analysis – Financial Results
Complete financial analysis of COLTENE Holding AG (CLTN.SW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of COLTENE Holding AG, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság (MOL.BD) Income Statement Analysis – Financial Results
- Nedbank Group Limited (NED.JO) Income Statement Analysis – Financial Results
- BlackStar Enterprise Group, Inc. (BEGI) Income Statement Analysis – Financial Results
- China SXT Pharmaceuticals, Inc. (SXTC) Income Statement Analysis – Financial Results
- Sears Canada Inc. (SRSCQ) Income Statement Analysis – Financial Results
COLTENE Holding AG (CLTN.SW)
About COLTENE Holding AG
COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. It offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, and characterizations; and endodontics products, such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, and endo accessories. The company also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams and dam kits, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products. In addition, it offers infection control products, which include ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers; rotary instruments, such as diamond and carbide burs, polishers, kits, and accessories; and laboratory products comprising gingiva masks, lab putty products, model making products, waxes, occlusion control products, accessories, HP burs, and silicone polishers. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 242.73M | 267.13M | 279.24M | 248.35M | 273.83M | 203.95M | 167.99M | 160.67M | 154.50M | 162.35M | 160.01M | 158.08M | 146.13M | 153.58M | 151.39M | 166.42M | 274.23M | 249.86M | 246.89M |
| Cost of Revenue | 86.80M | 98.71M | 102.12M | 96.93M | 95.66M | 63.26M | 47.92M | 45.61M | 47.19M | 48.20M | 47.74M | 46.78M | 44.49M | 44.11M | 43.15M | 45.70M | 88.72M | 82.57M | 83.40M |
| Gross Profit | 155.93M | 168.41M | 177.12M | 151.43M | 178.17M | 140.70M | 120.07M | 115.06M | 107.31M | 114.15M | 112.28M | 111.29M | 101.64M | 109.47M | 108.24M | 120.72M | 185.51M | 167.30M | 163.49M |
| Gross Profit Ratio | 64.24% | 63.05% | 63.43% | 60.97% | 65.07% | 68.99% | 71.47% | 71.61% | 69.46% | 70.31% | 70.17% | 70.40% | 69.55% | 71.28% | 71.50% | 72.54% | 67.65% | 66.96% | 66.22% |
| Research & Development | 10.24M | 8.57M | 9.05M | 9.47M | 10.89M | 8.15M | 5.29M | 4.70M | 4.47M | 5.35M | 4.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 23.05M | 3.71M | 5.43M | 3.78M | 5.18M | 5.85M | 2.88M | 3.77M | 2.95M | 57.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 90.15M | 82.92M | 81.05M |
| Selling & Marketing | 7.72M | 29.73M | 27.08M | 24.61M | 36.37M | 17.51M | 14.32M | 13.36M | 12.06M | 7.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.21M | 0.00 | 0.00 | 0.00 |
| SG&A | 30.77M | 33.44M | 32.51M | 28.40M | 41.55M | 23.36M | 17.20M | 17.13M | 15.01M | 64.89M | 57.05M | 0.00 | 0.00 | 0.00 | 0.00 | 26.21M | 90.15M | 82.92M | 81.05M |
| Other Expenses | 96.44M | 100.06M | 100.82M | 90.93M | 104.61M | 93.45M | 77.39M | 74.14M | 71.91M | 91.75M | 92.83M | 94.27M | 89.39M | 91.02M | 87.90M | 69.59M | 57.16M | 58.77M | 60.97M |
| Operating Expenses | 127.21M | 133.50M | 133.33M | 119.32M | 146.16M | 116.81M | 94.59M | 91.26M | 86.91M | 91.75M | 92.83M | 94.27M | 89.39M | 91.02M | 87.90M | 95.80M | 147.31M | 141.69M | 142.02M |
| Cost & Expenses | 223.12M | 232.21M | 235.45M | 216.25M | 241.82M | 180.07M | 142.51M | 136.87M | 134.10M | 139.94M | 140.57M | 141.06M | 133.88M | 135.14M | 131.05M | 141.50M | 236.02M | 224.26M | 225.42M |
| Interest Income | 37.00K | 34.00K | 23.00K | 22.00K | 32.00K | 28.00K | 27.00K | 15.00K | 37.00K | 81.00K | 88.00K | 121.00K | 92.00K | 1.24M | 656.00K | 617.00K | 1.20M | 3.32M | 1.91M |
| Interest Expense | 837.00K | 232.00K | 415.00K | 795.00K | 781.00K | 476.00K | 302.00K | 343.00K | 563.00K | 958.00K | 879.00K | 1.13M | 3.34M | 2.68M | 372.00K | 2.73M | 4.76M | 9.27M | 8.60M |
| Depreciation & Amortization | 6.85M | 6.72M | 6.44M | 6.03M | 6.10M | 5.56M | 5.71M | 5.61M | 5.48M | 5.27M | 5.19M | 4.96M | 4.93M | 4.72M | 4.35M | 4.22M | 9.60M | 9.38M | 9.87M |
| EBITDA | 23.80M | 39.88M | 48.05M | 26.48M | 38.11M | 30.94M | 31.19M | 29.41M | 25.87M | 27.09M | 23.07M | 21.38M | 15.13M | 18.67M | 25.13M | 27.44M | 30.25M | 41.95M | 31.34M |
| EBITDA Ratio | 9.81% | 14.93% | 17.21% | 15.52% | 12.79% | 14.35% | 18.17% | 18.60% | 15.50% | 16.69% | 14.42% | 13.34% | 11.82% | 15.35% | 16.60% | 17.88% | 17.44% | 14.00% | 12.69% |
| Operating Income | 19.61M | 34.91M | 43.80M | 23.26M | 32.01M | 23.68M | 25.49M | 23.31M | 20.39M | 22.41M | 19.45M | 17.02M | 12.25M | 18.44M | 20.34M | 24.92M | 35.23M | 30.08M | 27.19M |
| Operating Income Ratio | 8.08% | 13.07% | 15.68% | 9.37% | 11.69% | 11.61% | 15.17% | 14.51% | 13.19% | 13.80% | 12.15% | 10.77% | 8.38% | 12.01% | 13.43% | 14.98% | 12.85% | 12.04% | 11.01% |
| Total Other Income/Expenses | -3.49M | -1.98M | -2.60M | -5.23M | -3.87M | -2.20M | -973.00K | 134.00K | -2.48M | -1.55M | -2.44M | -1.73M | -3.25M | -5.23M | 74.00K | -2.11M | -628.00K | -1.15M | -3.81M |
| Income Before Tax | 16.12M | 32.94M | 41.20M | 18.03M | 28.14M | 21.44M | 24.51M | 23.44M | 17.90M | 20.86M | 17.00M | 14.99M | 9.00M | 13.21M | 20.41M | 22.81M | 33.45M | 28.93M | 23.38M |
| Income Before Tax Ratio | 6.64% | 12.33% | 14.75% | 7.26% | 10.28% | 10.51% | 14.59% | 14.59% | 11.59% | 12.85% | 10.63% | 9.48% | 6.16% | 8.60% | 13.48% | 13.71% | 12.20% | 11.58% | 9.47% |
| Income Tax Expense | 4.17M | 6.94M | 9.49M | 9.80M | 8.11M | 6.53M | 5.45M | 6.18M | 4.57M | 5.23M | 3.81M | 5.46M | 3.01M | 4.00M | 4.05M | 5.13M | 7.16M | -6.29M | -5.25M |
| Net Income | 11.95M | 26.00M | 31.71M | 8.23M | 20.03M | 14.91M | 19.06M | 17.27M | 13.34M | 15.63M | 13.19M | 9.53M | 5.99M | 9.29M | 16.36M | 48.07M | 26.30M | 22.64M | 18.12M |
| Net Income Ratio | 4.92% | 9.73% | 11.36% | 3.31% | 7.32% | 7.31% | 11.35% | 10.75% | 8.63% | 9.63% | 8.24% | 6.03% | 4.10% | 6.05% | 10.80% | 28.88% | 9.59% | 9.06% | 7.34% |
| EPS | 2.00 | 4.35 | 5.31 | 1.38 | 3.35 | 3.16 | 4.52 | 4.10 | 3.16 | 3.71 | 3.13 | 2.33 | 1.36 | 2.24 | 3.94 | 10.55 | 5.67 | 4.88 | 3.87 |
| EPS Diluted | 2.00 | 4.35 | 5.31 | 1.38 | 3.35 | 3.16 | 4.52 | 4.10 | 3.16 | 3.71 | 3.13 | 2.33 | 1.36 | 2.24 | 3.94 | 10.55 | 5.67 | 4.88 | 3.87 |
| Weighted Avg Shares Out | 5.98M | 5.97M | 5.97M | 5.98M | 5.97M | 4.71M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.19M | 4.15M | 4.15M | 4.15M | 4.56M | 4.63M | 4.64M | 4.68M |
| Weighted Avg Shares Out (Dil) | 5.98M | 5.97M | 5.97M | 5.98M | 5.97M | 4.71M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.19M | 4.15M | 4.15M | 4.15M | 4.56M | 4.63M | 4.64M | 4.68M |
Source: https://incomestatements.info
Category: Stock Reports